CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics Statistics
Share Statistics
CRISPR Therapeutics has 86.36M shares outstanding. The number of shares has increased by 1.01% in one year.
| 86.36M |
| 1.01% |
| 0.49% |
| 76.5% |
| n/a |
| 1,023 |
| 0.05% |
Short Selling Information
The latest short interest is 21.07M, so 24.39% of the outstanding shares have been sold short.
| 21.07M |
| 24.39% |
| 27.73% |
| 9.88 |
Valuation Ratios
The PE ratio is -9.07 and the forward PE ratio is -8.65. CRISPR Therapeutics's PEG ratio is -0.07.
| -9.07 |
| -8.65 |
| 94.87 |
| 1.5 |
| 1.72 |
| -22.95 |
| -0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CRISPR Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 22.07, with a Debt / Equity ratio of 0.12.
| 22.07 |
| 22.07 |
| 0.12 |
| -0.5 |
| -1.55 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $89,058.52 |
| $-931,938.93 |
| 393 |
| 0.02 |
| n/a |
Taxes
| 3.59M |
| -0.99% |
Stock Price Statistics
The stock price has increased by -27.56% in the last 52 weeks. The beta is 1.74, so CRISPR Therapeutics's price volatility has been higher than the market average.
| 1.74 |
| -27.56% |
| 36.86 |
| 43.36 |
| 65.17 |
| 2,057,009 |
Income Statement
In the last 12 months, CRISPR Therapeutics had revenue of 35M and earned -366.25M in profits. Earnings per share was -4.34.
| 35M |
| 37.31M |
| -466.57M |
| -366.25M |
| -447.31M |
| -466.57M |
| -4.34 |
Balance Sheet
The company has 298.26M in cash and 223.69M in debt, giving a net cash position of 74.56M.
| 298.26M |
| 223.69M |
| 74.56M |
| -1.37B |
| 2.17B |
| 1.75B |
Cash Flow
In the last 12 months, operating cash flow was -142.77M and capital expenditures -1.9M, giving a free cash flow of -144.68M.
| -142.77M |
| -1.9M |
| -144.68M |
| -1.71 |
Margins
Gross margin is 106.61%, with operating and profit margins of -1333.05% and -1046.43%.
| 106.61% |
| -1333.05% |
| -1036.19% |
| -1046.43% |
| -1278.02% |
| -1333.05% |
| -413.36% |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CRSP is $81.5, which is 94.4% higher than the current price. The consensus rating is "Buy".
| $81.5 |
| 94.4% |
| Buy |
| 16 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 5.02 |
| 1 |